CD8A and COVID-19: For this, we directly stained PBMC from 63 COVID-19 patients for the complement subunits C3b and C1q and quantified the percentage of lymphocytes (CD4+, CD8+, or B cells) with complement deposition on their membranes (Figure 3A; Supplementary Figure S5A).